Next Article in Journal
Strategies for Producing Low FODMAPs Foodstuffs: Challenges and Perspectives
Next Article in Special Issue
Metabolomic Characteristics of Cecum Contents in High-Fat-Diet-Induced Obese Mice Intervened with Different Fibers
Previous Article in Journal
Bidirectional Effects of Mao Jian Green Tea and Its Flavonoid Glycosides on Gastrointestinal Motility
Previous Article in Special Issue
Effect of Enyzmes on the Quality and Predicting Glycaemic Response of Chinese Steamed Bread
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

In Vitro Digestion and Fecal Fermentation of Low-Gluten Rice and Its Effect on the Gut Microbiota

1
Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi 214122, China
2
State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China
3
Department of Hepatobiliary Surgery, Affiliated Hospital of Jiangnan University, Wuxi 214122, China
*
Authors to whom correspondence should be addressed.
Foods 2023, 12(4), 855; https://doi.org/10.3390/foods12040855
Submission received: 13 December 2022 / Revised: 11 February 2023 / Accepted: 13 February 2023 / Published: 16 February 2023

Abstract

:
Low-gluten rice is part of a special diet for chronic kidney disease patients, but its digestive mechanism in the gastrointestinal tract is unclear. In this study, low-gluten rice (LGR), common rice (CR), and rice starch (RS) were used as experimental samples, and their digestion and bacterial fermentation were simulated using an in vitro gastrointestinal reactor to investigate the mechanism of the effect of LGR on human health. The starch digestibility of CR was higher than that of LGR, with statistically significant differences. LGR has growth-promoting and metabolic effects on Akkermansia muciniphila. Among the beneficial metabolites, the concentration of short-chain fatty acids (SCFAs) from LGR reached 104.85 mmol/L, an increase of 44.94% (versus RS) and 25.33% (versus CR). Moreover, the concentration of lactic acid reached 18.19 mmol/L, an increase of 60.55% (versus RS) and 25.28% (versus CR). Among the harmful metabolites, the concentration of branched-chain fatty acids (BCFAs) in LGR was 0.29 mmol/L and the concentration of ammonia was 2.60 mmol/L, which was 79.31% and 16.15% lower than CR, respectively. A significant increase in the concentration of the beneficial intestinal bacteria Bacteroides and Bifidobacterium occurred from LGR. The 16s rDNA sequencing showed that the abundance of the Bacteroidetes and Firmicutes increased and the abundance of the Proteobacteria and Fusobacteria decreased. Thus, LGR has positive effects on digestion and gut microbiota structure and metabolism in humans.

Graphical Abstract

1. Introduction

Chronic kidney disease is a major health hazard for human beings, with at least 850 million people suffering from kidney disease worldwide, including more than 400 million in Asia [1]. A low gluten diet is a staple for people with chronic kidney disease. This diet benefits people with chronic kidney disease as it delays the progression of kidney disease and improves intestinal function. Hansen et al. [2] found that a low gluten diet induced moderate changes in the gut microbiome, reduced fasting and postprandial hydrogen exhalation, and improved abdominal distension. Rice is one of the main diets of Asians. The relative content of protein in rice is approximately 8% to 10% and can be divided into albumin, globulin, alcoholic protein, and glutenin according to their solubility [3]. Gluten is the main protein storage in rice seeds and the main soluble protein. Moreover, gluten is rich in lysine which is easily digested and absorbed by the human body, is located in protein body II inside the endosperm cells, and accounts for approximately 80% of the total protein dry mass of rice [4,5]. However, excessive absorption of soluble protein may lead to disorders of protein metabolism, especially for patients with kidney disease, who should not consume rice with a soluble protein amount fraction of more than 4% [6,7]. Low-gluten rice (LGR) may provide potential health benefits for patients with chronic kidney disease, but only few studies have examined the effects of LGR on the structure and metabolism of gut microbiota in the large intestine after digestion through the stomach and small intestine.
Inhabited by a highly diverse microbial community composed mainly of bacteria, the human gut is the largest and most complex micro-ecosystem in the human body [8,9]. In addition to absorbing nutrients and excreting waste, the microbiota present in the human gastrointestinal tract can also produce beneficial or harmful substances which can affect human health, such as short-chain fatty acids (SCFAs) and branched-chain fatty acids (BCFAs). Bifidobacterium and Lactobacillus synthesize vitamins required by the body, promote the production of SCFAs and inhibit the production of BCFAs. Among SCFAs acetic acid promotes the development of peripheral tissues, and propionic acid stimulates hepatocyte growth [10]. Butyric acid stimulates the growth of intestinal epithelial tissues and promotes normal maturation and differentiation of intestinal cells [11]. However, BCFAs are irritating to the mucosa and may trigger inflammation [12,13]. Akkermansia muciniphila is valuable in improving host metabolic function and immune response by affecting metabolism through enhancing the integrity of the intestinal wall, thereby reducing intestinal permeability and associated endotoxemia [14]. Fecal coliform can cause a variety of local tissue and organ infections in humans and animals under certain conditions. Clearly, gut microbiota is an important player in human metabolism as it can (1) provide beneficial or harmful substances, enzymes, and energy to human metabolism, (2) help clarify intestinal function and hidden metabolic or immune disease problems, as gut microbiota are important participants in human metabolism, and (3) provide multifaceted probing data for medical diagnosis [15]. Therefore, studying the beneficial effects of LGR on gut microbiota would be beneficial.
The use of in vivo digestion to examine the digestive process of food and drugs in the human body often has the disadvantages of high cost, long experimental period, and poor reliability [16]. Thus, the trend has gradually evolved toward that of in vitro digestion to simulate the human intestine. In vitro digestion is divided into static and dynamic simulations. Static simulation cannot model the physical processes such as shearing and mixing that occur in vivo and does not absorb the metabolites of the digestion process. Dynamic simulation compensates for the shortcomings of static simulation by not only being able to simulate physical processes in the gastrointestinal tract but also allowing for the observation of other changes that occur at different digestion times [17].
In this study, LGR, common rice (CR), and rice starch (RS) were used as experimental samples to investigate the digestion kinetics of LGR in the stomach and small intestine and the mechanism of influence on intestinal gut microbiota using the developed dynamic simulation equipment, namely the bionic gastrointestinal reactor (BGR) [18] and bionic colon model (BCM) [19], to elucidate the mechanism of influence of a low-gluten diet on the host for reference.

2. Materials and Methods

2.1. Experimental Materials

LGR was provided by the Institute of Crop Science, the Chinese Academy of Agricultural Sciences, Beijing, China; CR was purchased from supermarkets; and other reagents were purchased from the Sinopharm Chemical Reagent Co., Shanghai, China.

2.2. In Vitro Gastric and Small Intestine Digestion

The digestion process was modified from the previous method by referring to Li et al. [20]. The prepared rice was added to the BGR (Supplementary Figure S1) by feeding peristaltic pump flow, along with saliva, gastric juice, and intestinal fluid as described in the literature. Extractions with trichloroacetic acid (TCA) and subsequently quantified the nitrogenous compounds in the TCA soluble extract to study the extent of starch breakdown and protein hydrolysis in the simulated chyme. Digests were treated rapidly with TCA at 4 °C to stop all enzymatic hydrolysis reactions and to separate small peptides, amino acids and sugars from high molecular weight proteins and enzymes. Five (5) mL of minced food was treated with 700 μL of 100% TCA (12% final TCA concentration) in a centrifuge tube and the mixture was vortexed. After incubation at 4 °C for 1 h, the sample was centrifuged at 14,000× g for 45 min at 4 °C. The supernatant was aspirated, divided into aliquots and stored at −20 °C prior to analysis. Monosaccharides were applied enzymatically with glucose oxidase and measured colorimetrically, protein hydrolysis was determined by micro Kjeldahl method by equations referring to C. Villemejane et al. [21].

2.3. Culture of Gut Microbiota in the Colon In Vitro

The fermentation process was performed according to Li et al. [19]. At 37 °C, A. muciniphila, Bifidobacterium, Lactobacillus, Bacteroid, fecal coliform, total anaerobic bacteria, and fecal were cultured using selection media (Supplementary Table S1). The OD600 value of bacterial solution was determined by ultraviolet spectrophotometer (Nanodrop 2000, Wilmington, DE, USA) and the MRS liquid culture medium was used as a reference to determine an initial OD600 value, and then the culture was continued. Informed consent was obtained from all participants, as required by the Human Ethics Committee of Affiliated Hospital of Jiangnan University (approval No. JY-0016) on the Use of Humans as Experimental Subjects. The feces of three selected volunteers were mixed well and inoculated into the BCM, and after 24 h of colonization, the digested RS, CR, and LGR were added to the BCM for fermentation.

2.4. SCFAs, BCFAs, and Lactic Acid

SCFAs, BCFAs, and lactic acid were extracted from the samples using ether and ascertained with the Agilent (7820 A, Palo Alto, CA, USA) gas chromatograph following the method of Wang et al. [22]. The SCFAs and BCFAs were separated using a HP-INNOWAX (19091N-133, Billerica, MA, USA) capillary column with an inner diameter of 250 μm and a film thickness of 0.25 μm. The chromatographic ramp-up procedure was as follows: an initial temperature of 60 °C was maintained for 1 min, ramped up to 190 °C at 20 °C/min and maintained for 7.5 min; the injection port temperature was 220 °C; the hydrogen flame ionization detector temperature was 250 °C; the injection volume was 5 μL; the shunt ratio was 20:1; the carrier gas was high-purity nitrogen (purity > 99.999%) at a flow rate of 1.5 mL/min; the tail gas was high-purity nitrogen (purity > 99.999%) at a flow rate of 30 mL/min; the hydrogen flow rate was 40 mL/min; and the air flow rate was 400 mL/min.

2.5. Determination of the Ammonia Content

The ammonia content in the fermentation broth was determined using the indophenol blue-spectrophotometric method. First, Solution A was obtained by adding 5 g of phenol and 2.0 mL of sodium nitrosoferricyanide solution (1.25%) to 400 mL of water and fixing the volume to 500 mL. Then, Solution B was obtained by adding 2.5 g of NaOH, 3.5 mL of NaClO, and 2.0 g of trisodium citrate to 400 mL of water and fixing the volume to 500 mL. Subsequently, two fermentation broth samples of 100 μL each were singly introduced to 5 mL of Solution A and Solution B, mixed thoroughly, and stored at 37 °C. The resulting solutions were placed in a water bath at 37 °C for 20 min, removed to cool to room temperature (Wuxi, 20 °C), and measured for absorbance at 637 nm in the Bio-rad (Hercules, CA, USA).

2.6. S rDNA Amplicon Sequencing Method

The DNA extracted from the fermentation broth was diluted to 1 ng/μL, and the 16S V3–V4 region was PCR amplified using the specific primers with Barcode as the template for the diluted genomic DNA. The obtained PCR products were then purified, and library construction was performed by using the TruSeq® DNA PCR-Free Sample Preparation Kit. The constructed library was quantified using Qubit and Q-PCR and subsequently sequenced on the machine using NovaSeq6000. Based on the characteristics of the amplified 16S region, a small fragment library was constructed, and the library was sequenced based using the Illumina NovaSeq (San Diego, CA, USA) sequencing platform. The sequencing was entrusted to the Beijing NovaSeq Technology Co.

2.7. Statistical Analysis

All experiments were repeated three times and averaged, and ANOVA was performed using the F-test of the software SPSS (Version 26.0, Statistical Product Service Solutions), and the Duncan test was used to analyze the significance of differences, with p < 0.05 being considered significant. Graphpad Prism (Version 8.4.3; Graphpad Software) was used for graphing.

3. Results and Discussion

3.1. Starch Digestibility

Figure 1 shows the starch and protein digestibility of LGR, CR and RS as measured using the BGR. The starch and protein digestibility of CR was higher than that of LGR with a significant difference (p < 0.05), probably because of the cross-linking of insoluble proteins in LGR with starch, a feature that affects starch digestibility [23]. Starch-binding proteins are often referred to as starch granule-associated proteins, and they form a protective network around the starch granules, making them less susceptible to digestion by digestive enzymes. Consistent with the results from Amina et al. [24] which indicates that removal of proteins increases starch digestibility of rice, CR has high gluten content, making it a soluble protein which is easily hydrolyzed, but LGR has low gluten content, is a highly alcoholic soluble protein, has a dense structure, and is not easily hydrolyzed. Low starch digestibility results in a lower rate of conversion of starch to sugar, making the intake of LGR healthier for some people who need to strictly limit their sugar and protein intake.

3.2. A. muciniphila Growth and Metabolism

To investigate the in vivo effect of LGR on A. muciniphila, the BCM was employed to ferment A. muciniphila using RS, CR, and LGR as nutritional composition. The changes in colony concentration and metabolite content were analyzed to assess the effect of LGR on A. muciniphila growth and metabolism. As shown in Figure 2a,b, the OD600 and colony concentration of A. muciniphila with LGR as carbon source were higher than those with RS and CR, with significant differences (p < 0.05). Compared with RS, LGR had a 24.75% increase in OD600 and 0.58 log10 cfu/mL increase in colony concentration. Thus, LGR could promote A. muciniphila growth. Zhang et al. [14] found that A. muciniphila was associated with many metabolic diseases and had a preventive effect on obesity and type 2 diabetes, as well as reducing the risk of cardiovascular disease, with the SCFAs produced by its metabolism being one of the main factors of action [25]. As shown in Figure 2c, the concentration of total SCFAs in LGR reached 54.33 mmol/L, which was 28.56% higher than that in RS; the concentration of acetic acid reached 28.09 mmol/L, which was 22.61% higher than that in RS; the concentration of propionic acid reached 26.68 mmol/L, which was not significantly different from that in RS and CR (p > 0.05). The concentration of butyric acid reached 15.15 mmol/L in LGR, which was 65.57% and 23.67% higher than that in RS and CR, respectively. The concentration of lactic acid was also elevated in LGR at 15.4 mmol/L, which was 89.42% and 42.59% higher than that with RS and CR. The present results suggest that LGR not only promotes A. muciniphila growth but also stimulates the production of beneficial SCFAs and lactate metabolism by A. muciniphila. By contrast, BCFAs metabolized by gut microbiota may have negative effects on human health [26]. As shown in Figure 2d, no significant difference was noted between the isobutyric and isovaleric acid content in LGR compared with those in CR, and the concentration of total BCFAs in LGR was 0.64 mmol/L, which was 37.50% lower than that in CR. The concentration of ammonia in LGR was also 2.36 mmol/L, which was 23.31% lower than that in CR. Comparisons with RS revealed no significant differences. A. muciniphila may prefer to feed on alcohol-soluble proteins, and LGR is rich in alcohol-soluble proteins, which can better promote A. muciniphila growth and produce more short-chain fatty acids such as acetate and propionic acid during metabolism, and inhibit the production of branched-chain fatty acids through competitive rejection, making it beneficial to human health.

3.3. Gut Microbiota Growth and Metabolism

To investigate LGR-induced in vivo changes of microbial growth and metabolism in the colon, the fermentation of feces using the BCM with RS, CR, and LGR as nutritional composition were used to analyze the changes of microbial concentration and metabolite content and assess the effects of LGR on the growth and metabolism of gut microbiota. The results of the partial gut microbiota counting using the plate counting method are shown in Figure 3a. The concentration of intestinal beneficial bacteria in LGR increased compared with that in RS and CR, with the most significant increase in Bifidobacterium and Bacteroides, with concentrations of 8.27 log10 cfu/mL and 8.92 log10 cfu/mL. In terms of enteropathogenic bacteria, the fecal E. coli concentration in LGR was 7.39 log10 cfu/mL. Thus, LGR could increase the concentration of beneficial intestinal bacteria and decrease the concentration of harmful intestinal bacteria in healthy people.
In terms of beneficial metabolites, Figure 3b shows that compared with RS and CR, LGR reached a concentration of 49.70 mmol/L of acetic acid, which increased by 33.60% and 18.42%, respectively; of 26.68 mmol/L of propionic acid, which increased by 47.32% compared with RS; of 28.47 mmol/L of butyric acid, which increased by 67.18% and 41.78%, relative to RS and CR, respectively; and the total SCFAs concentration of LGR reached 104.85 mmol/L, which was 44.94% and 25.33% higher than that of RS and CR, respectively. The lactate concentration was also significantly higher in LGR compared to RS, reaching 18.19 mmol/L, an increase of 60.55%. The high content of soluble gluten in CR shifted the microbiota to protein fermentation, while the low content of gluten in LGR shifted the microbiota to carbohydrate fermentation, with SCFAs and lactate as the predominant metabolites. Thus, LGR has a significant facilitative effect on the metabolism of SCFAs and lactate by the gut microbiota.
In terms of harmful metabolites, Figure 3c shows that the concentrations of isobutyric acid, isovaleric acid, total BCFAs, and ammonia were significantly reduced in LGR, where the concentration of isobutyric acid was 0.14 mmol/L, which was 85.71% lower than that of RS; the concentration of isovaleric acid was 0.15 mmol/L, which was 73.33% lower than that of CR; the concentration of total BCFAs was 0.29 mmol/L which was 79.31% lower than that of RS; and the concentration of ammonia was 2.60 mmol/L, which was 16.15% lower than that of CR. The high content of soluble gluten in CR allows the microbiota to shift to protein fermentation [3], but the low gluten content in LGR means relatively more fermentable carbohydrates are the main substance.

3.4. Gut Microbiota Structure

As shown in Figure 4a, the dominant microbiota at the phylum level consisted of Bacteroidetes, Firmicutes, Proteobacteria, and Fusobacteria, accounting for more than 95% of the total microbiota. Compared to RS, Bacteroidetes and Firmicutes increased and Proteobacteria and Fusobacteria decreased in CR and LGR, with the change being particularly pronounced in LGR. This outcome indicates that Bacteroidetes and Firmicutes have a mutually reinforcing symbiotic relationship, and they jointly promote host energy absorption and storage [27]. Moreover, Proteobacteria and Fusobacteria are typical markers of gut microbiota dysbiosis [28], and the significant decrease in the number of Proteobacteria in LGR may be caused by the increased production of SCFAs and lactic acid, which, in turn, lowered the intestinal pH and inhibited the growth of harmful intestinal bacteria. Therefore, LGR could improve the structure of gut microbiota at the genus level in healthy people and promote the ecological balance of gut microbiota. As shown in Figure 4b, the composition of the gut microbiota varied considerably at the genus level. Compared to the RS and CR counterparts, the relative abundance of Bilophila, Parabacteroides, and Flavonifracto were significantly higher. Bilophila can cause primary septic infections and severe secondary infections [29], Parabacteroides can produce beneficial metabolic end products such as acetic acid and succinic acid [30], and Flavonifracto consist mostly of conditionally pathogenic bacteria [31]. The relative abundance of Fusobacterium, Citrobacter, and Klebsiella, which are pathogenic [32,33,34], were significantly reduced in the LGR, as consistent with the results of Bonder et al. [35] who found that low gluten grains reduced the abundance of Fusobacterium. The relative abundance of Fusobacterium in the LGR. The relative abundance of Bacillus, Faecalibacterium, Romboutsia, and Megasphaera were significantly increased. Among these, Bacillus could antagonize harmful bacteria in the intestine, Faecalibacterium was the main genus of butyric acid-producing bacteria [36], Romboutsia had an important role in maintaining the health status of the host [37], and Megasphaera was involved in the fermentation of lactic acid and fructose in humans [38]. In addition, LGR can also effectively increase the richness and uniformity of gut microbiota (Figure 4c). Taken together, these results suggest that LGR can improve the structure of the host gut microbiota and promote the increase in the abundance of beneficial bacterial genera.

4. Conclusions

The results of this study showed that starch and protein digestibility of CR was higher than that of LGR during in vitro gastric and small intestinal digestion. LGR promotes the metabolic production and probiotic growth of SCFAS and lactic acid, and inhibits the metabolic production and harmful bacterial growth of BCFAs and ammonia. However, excessive intake of LGR may also stimulate disproportionate growth of certain bacteria or pathogens, which may endanger intestinal homeostasis. As far as the current results are concerned, further in vivo digestion experimental studies in animals are needed to obtain more detailed gut microbiota regulatory mechanisms, which will lay a solid foundation for the mechanism of LGR for human health promotion.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/foods12040855/s1, Figure S1: dynamic simulation equipment; Table S1: Components of selective media.

Author Contributions

Z.-T.L.: conceived and designed the experiments; analyzed and interpreted the data; wrote the paper. S.-X.H.: conceived and designed the experiments; performed the experiments; analyzed and interpreted the data; wrote the paper. J.-Y.P.: analyzed and interpreted the data; wrote the paper. Y.-Y.W.: performed the experiments; analyzed and interpreted the data. Y.J.: performed the experiments; analyzed and interpreted the data. M.-J.G.: performed the experiments; analyzed and interpreted the data. S.X.: conceived and designed the experiments; analyzed and interpreted the data; contributed reagents, materials, analysis tools or data; wrote the paper. X.-B.Z.: contributed reagents, materials, analysis tools or data; wrote the paper. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by the National Key Research and Development Plan (2021YFC2101100), Project funded by China Postdoctoral Science Foundation (2021M701463, 2022T150272) and Jiangsu Excellent Postdoctoral Program (2022ZB499).

Institutional Review Board Statement

The study was approved by the ethics committee (approval No. JY-0016) to the department of Jiangnan University, Human Ethics Committee of Affiliated Hospital.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available due to experimental restrictions.

Conflicts of Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

  1. Watanabe, S.; Ohtsubo, K.I. Low-Protein Diet: History and Use of Processed Low-Protein Rice for the Treatment of Chronic Kidney Disease. Foods 2021, 10, 2255. [Google Scholar] [CrossRef] [PubMed]
  2. Hansen, L.B.S.; Roager, H.M.; Søndertoft, N.B.; Gøbel, R.J.; Kristensen, M.; Vallès-Colomer, M.; Vieira-Silva, S.; Hansen, T.; Lauritzen, L.; Gupta, R.; et al. A low-gluten diet induces changes in the intestinal microbiome of healthy Danish adults. Nat. Commun. 2018, 9, 4630. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Al-Rufaye, T.A.H.; Al-Sheikh, W.M.S.; Ghaleb, I.K. Detection of Lgc1 Gene Low Glutelin Content in Rice Cultivars Iraq using Indel Markers. J. Glob. Pharma Technol. 2018, 10, 19–196. [Google Scholar]
  4. Ji-Yoon, L.; Jong-Hee, L.; Jun-Hyun, C.; Sang-Yeol, K.; Choon-Song, K.; Young-Bo, S.; Un-Sang, Y.; Choon-Woo, L.; Min-Hee, N. Analysis of Eating Quality in Recombinant Inbred Lines and Selection of Elite Line with Low Glutelin Content in Rice. Korean J. Breed. Sci. 2012, 44, 136–141. [Google Scholar]
  5. Guo, D.; Ling, X.; Zhou, X.; Li, X.; Wang, J.; Qiu, S.; Yang, Y.; Zhang, B. Evaluation of the Quality of a High-Resistant Starch and Low-Glutelin Rice (Oryza sativa L.) Generated through CRISPR/Cas9-Mediated Targeted Mutagenesis. J. Agric. Food Chem. 2020, 68, 9733–9742. [Google Scholar] [CrossRef]
  6. Li, G.-h.; Chen, Y.-l.; Ding, Y.-f.; Geng, C.-m.; Li, Q.; Liu, Z.-h.; Wang, S.-h.; Tang, S. Charactering protein fraction concentrations as influenced by nitrogen application in low-glutelin rice cultivars. J. Integr. Agric. 2016, 15, 537–544. [Google Scholar] [CrossRef] [Green Version]
  7. Wang, Y.H.; Liu, S.J.; Ji, S.L.; Zhang, W.W.; Wang, C.M.; Jiang, L.; Wan, J.M. Fine mapping and marker-assisted selection (MAS) of a low glutelin content gene in rice. Cell Res. 2005, 15, 622–630. [Google Scholar] [CrossRef]
  8. Wang, H.; Wei, C.-X.; Min, L.; Zhu, L.-Y. Good or bad: Gut bacteria in human health and diseases. Biotechnol. Biotechnol. Equip. 2018, 32, 1075–1080. [Google Scholar] [CrossRef] [Green Version]
  9. Chong, P.P.; Koh, A.Y. The gut microbiota in transplant patients. Blood Rev. 2020, 39, 100614. [Google Scholar] [CrossRef]
  10. Fukui, H.; Xu, X.; Miwa, H. Role of Gut Microbiota-Gut Hormone Axis in the Pathophysiology of Functional Gastrointestinal Disorders. J. Neurogastroenterol. Motil. 2018, 24, 367–386. [Google Scholar] [CrossRef]
  11. Makki, K.; Deehan, E.C.; Walter, J.; Bäckhed, F. The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease. Cell Host Microbe 2018, 23, 705–715. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Barczynska, R.; Litwin, M.; Slizewska, K.; Szalecki, M.; Berdowska, A.; Bandurska, K.; Libudzisz, Z. Bacterial Microbiota and Fatty Acids in the Faeces of Overweight and Obese Children. Pol. J. Microbiol. 2018, 67, 339–345. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Quigley, E.M.M. Gut bacteria in health and disease. Gastroenterol. Hepatol. 2013, 9, 560–569. [Google Scholar]
  14. Zhang, T.; Li, Q.; Cheng, L.; Buch, H.; Zhang, F. Akkermansia muciniphila is a promising probiotic. Microb. Biotechnol. 2019, 12, 1109–1125. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Qin, J.; Li, Y.; Cai, Z.; Li, S.; Zhu, J.; Zhang, F.; Liang, S.; Zhang, W.; Guan, Y.; Shen, D.; et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490, 55–60. [Google Scholar] [CrossRef] [PubMed]
  16. Verhoeckx, K.; Cotter, P.; López-Expósito, I.; Kleiveland, C.; Lea, T.; Mackie, A.; Requena, T.; Swiatecka, D.; Wichers, H. The Impact of Food Bioactives on Health; Springer: New York, NY, USA, 2015. [Google Scholar]
  17. Minekus, M. The TNO Gastro-Intestinal Model (TIM). In The Impact of Food Bioactives on Health: In Vitro and Ex Vivo Models; Verhoeckx, K., Cotter, P., Lopez-Exposito, I., Kleiveland, C., Lea, T., Mackie, A., Requena, T., Swiatecka, D., Wichers, H., Eds.; Springer: New York, NY, USA, 2015; pp. 37–46. [Google Scholar] [CrossRef] [Green Version]
  18. Li, Z.-t.; Zhu, L.; Zhang, W.-l.; Zhan, X.-b.; Gao, M.-j. New dynamic digestion model reactor that mimics gastrointestinal function. Biochem. Eng. J. 2020, 154, 107431. [Google Scholar] [CrossRef]
  19. Li, Z.T.; Wang, J.W.; Hu, X.H.; Zhu, L.; Jiang, Y.; Gao, M.J.; Zhan, X.B. The effects of high-fat foods on gut microbiota and small molecule intestinal gases: Release kinetics and distribution in vitro colon model. Heliyon 2022, 8, e10911. [Google Scholar] [CrossRef] [PubMed]
  20. Li, Z.T.; Hu, G.A.; Zhu, L.; Zhao, Z.C.; Yun, J.; Gao, M.J.; Zhan, X.B. In vitro digestion and fecal fermentation of highly resistant starch rice and its effect on the gut microbiota. Food Chem. 2021, 361, 130095. [Google Scholar] [CrossRef]
  21. Villemejane, C.; Denis, S.; Marsset-Baglieri, A.; Alric, M.; Aymard, P.; Michon, C. In vitro digestion of short-dough biscuits enriched in proteins and/or fibres using a multi-compartmental and dynamic system (2): Protein and starch hydrolyses. Food Chem. 2016, 190, 164–172. [Google Scholar] [CrossRef]
  22. Wang, L.; Hu, L.; Xu, Q.; Yin, B.; Fang, D.; Wang, G.; Zhao, J.; Zhang, H.; Chen, W. Bifidobacterium adolescentis Exerts Strain-Specific Effects on Constipation Induced by Loperamide in BALB/c Mice. Int. J. Mol. Sci. 2017, 18, 318. [Google Scholar] [CrossRef] [Green Version]
  23. Lu, X.; Ma, R.; Zhan, J.; Wang, F.; Tian, Y. The role of protein and its hydrolysates in regulating the digestive properties of starch: A review. Trends Food Sci. Technol. 2022, 125, 54–65. [Google Scholar] [CrossRef]
  24. Khatun, A.; Waters, D.L.E.; Liu, L. The impact of rice protein on in vitro rice starch digestibility. Food Hydrocoll. 2020, 109, 106072. [Google Scholar] [CrossRef]
  25. Chen, C.; Huang, Q.; Fu, X.; Liu, R.H. In Vitro fermentation of mulberry fruit polysaccharides by human fecal inocula and impact on microbiota. Food Funct. 2016, 7, 4637–4643. [Google Scholar] [CrossRef] [PubMed]
  26. Koenen, M.E.; Cruz Rubio, J.M.; Mueller, M.; Venema, K. The effect of agave fructan products on the activity and composition of the microbiota determined in a dynamic in vitro model of the human proximal large intestine. J. Funct. Foods 2016, 22, 201–210. [Google Scholar] [CrossRef]
  27. Cotter, P. Beneficial modulation of the gut microbiota. Int. J. Infect. Dis. 2016, 45, 38. [Google Scholar] [CrossRef] [Green Version]
  28. Pham, T.-P.-T.; Tidjani Alou, M.; Bachar, D.; Levasseur, A.; Brah, S.; Alhousseini, D.; Sokhna, C.; Diallo, A.; Wieringa, F.; Million, M.; et al. Gut Microbiota Alteration is Characterized by a Proteobacteria and Fusobacteria Bloom in Kwashiorkor and a Bacteroidetes Paucity in Marasmus. Sci. Rep. 2019, 9, 9084. [Google Scholar] [CrossRef] [Green Version]
  29. Peck, S.C.; Denger, K.; Burrichter, A.; Irwin, S.M.; Balskus, E.P.; Schleheck, D. A glycyl radical enzyme enables hydrogen sulfide production by the human intestinal bacterium Bilophila wadsworthia. Proc. Natl. Acad. Sci. USA 2019, 116, 3171–3176. [Google Scholar] [CrossRef] [Green Version]
  30. Rong, S.M.M.; Rodloff, A.C.; Stingu, C.-S. Diversity of antimicrobial resistance genes in Bacteroides and Parabacteroides strains isolated in Germany. J. Glob. Antimicrob. Resist. 2021, 24, 328–334. [Google Scholar] [CrossRef]
  31. Xuan, J.; Tarentino, A.L.; Grimwood, B.G.; Plummer, T.H.; Cui, T.; Guan, C.; Van Roey, P. Crystal structure of glycosylasparaginase from Flavobacterium meningosepticum. Protein Sci. A Publ. Protein Soc. 1998, 7, 774–781. [Google Scholar] [CrossRef] [Green Version]
  32. Bernardini, A.; Cuesta, T.; Tomás, A.; Bengoechea, J.A.; Martínez, J.L.; Sánchez, M.B. The intrinsic resistome of Klebsiella pneumoniae. Int. J. Antimicrob. Agents 2019, 53, 29–33. [Google Scholar] [CrossRef]
  33. Choudhuri, I.; Khanra, K.; Maity, P.; Patra, A.; Maity, G.N.; Pati, B.R.; Nag, A.; Mondal, S.; Bhattacharyya, N. Structure and biological properties of exopolysaccharide isolated from Citrobacter freundii. Int. J. Biol. Macromol. 2021, 168, 537–549. [Google Scholar] [CrossRef] [PubMed]
  34. Vidaurrazaga, M.M.; McKinley, G.F.; Camins, B.C. Postpartum Fusobacterium gonidiaformans bacteremia. Anaerobe 2020, 62, 102168. [Google Scholar] [CrossRef] [PubMed]
  35. Bonder, M.J.; Tigchelaar, E.F.; Cai, X.; Trynka, G.; Cenit, M.C.; Hrdlickova, B.; Zhong, H.; Vatanen, T.; Gevers, D.; Wijmenga, C.; et al. The influence of a short-term gluten-free diet on the human gut microbiome. Genome Med. 2016, 8, 45. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Leylabadlo, H.E.; Ghotaslou, R.; Feizabadi, M.M.; Farajnia, S.; Moaddab, S.Y.; Ganbarov, K.; Khodadadi, E.; Tanomand, A.; Sheykhsaran, E.; Yousefi, B.; et al. The critical role of Faecalibacterium prausnitzii in human health: An overview. Microb. Pathog. 2020, 149, 104344. [Google Scholar] [CrossRef] [PubMed]
  37. Maki, J.J.; Nielsen, D.W.; Looft, T. Complete Genome Sequence and Annotation for Romboutsia sp. Strain CE17. Microbiol. Resour. Announc. 2020, 9, e00382-20. [Google Scholar] [CrossRef] [PubMed]
  38. Srinivasan, S.; Beamer, M.A.; Fiedler, T.L.; Austin, M.N.; Sizova, M.V.; Strenk, S.M.; Agnew, K.J.; Nagana-Gowda, G.A.; Rabe, L.K.; Raftery, D.; et al. Characterization of novel megasphaera species from the female reproductive tract. Am. J. Obstet. Gynecol. 2018, 219, 648–649. [Google Scholar] [CrossRef]
Figure 1. Starch and protein digestibility of LGR, CR, and RS in dynamic digestion simulation.
Figure 1. Starch and protein digestibility of LGR, CR, and RS in dynamic digestion simulation.
Foods 12 00855 g001
Figure 2. Effect of LGR, CR, and RS on Akkermansia muciniphila growth and metabolism in dynamic fermentation simulation. Note: OD600 (a), growth concentration (b), changes in SCFAs (c), changes in BCFAs (d). The data are shown as the mean ± SD (n = 3) and analyzed using one−way ANOVA with Tukey’s test, differences marked with the same lowercase letter in the graph indicate that the differences are not significant (p > 0.05), different lowercase letters indicate significant differences (p < 0.05); LGR: low gluten rice; CR: common rice; RS: rice starch.
Figure 2. Effect of LGR, CR, and RS on Akkermansia muciniphila growth and metabolism in dynamic fermentation simulation. Note: OD600 (a), growth concentration (b), changes in SCFAs (c), changes in BCFAs (d). The data are shown as the mean ± SD (n = 3) and analyzed using one−way ANOVA with Tukey’s test, differences marked with the same lowercase letter in the graph indicate that the differences are not significant (p > 0.05), different lowercase letters indicate significant differences (p < 0.05); LGR: low gluten rice; CR: common rice; RS: rice starch.
Foods 12 00855 g002
Figure 3. Effect of LGR, CR, and RS on gut microbiota growth and metabolism in dynamic fermentation simulation. Note: changes in microbiota (a), changes in SCFAs (b), changes in BCFAs and amine (c). The data are shown as the mean ± SD (n = 3) and analyzed using one−way ANOVA with Tukey’s test, differences marked with the same lowercase letter in the graph indicate that the differences are not significant (p > 0.05), different lowercase letters indicate significant differences (p < 0.05); LGR: low gluten rice; CR: common rice; RS: rice starch.
Figure 3. Effect of LGR, CR, and RS on gut microbiota growth and metabolism in dynamic fermentation simulation. Note: changes in microbiota (a), changes in SCFAs (b), changes in BCFAs and amine (c). The data are shown as the mean ± SD (n = 3) and analyzed using one−way ANOVA with Tukey’s test, differences marked with the same lowercase letter in the graph indicate that the differences are not significant (p > 0.05), different lowercase letters indicate significant differences (p < 0.05); LGR: low gluten rice; CR: common rice; RS: rice starch.
Foods 12 00855 g003
Figure 4. Effect of LGR, CR, and RS on gut microbiota composition in dynamic fermentation simulation. Note: changes in phylum level (a), changes in genus level (b), changes in species diversity curve (c). LGR: low gluten rice; CR: common rice; RS: rice starch.
Figure 4. Effect of LGR, CR, and RS on gut microbiota composition in dynamic fermentation simulation. Note: changes in phylum level (a), changes in genus level (b), changes in species diversity curve (c). LGR: low gluten rice; CR: common rice; RS: rice starch.
Foods 12 00855 g004
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Li, Z.-T.; Han, S.-X.; Pu, J.-Y.; Wang, Y.-Y.; Jiang, Y.; Gao, M.-J.; Zhan, X.-B.; Xu, S. In Vitro Digestion and Fecal Fermentation of Low-Gluten Rice and Its Effect on the Gut Microbiota. Foods 2023, 12, 855. https://doi.org/10.3390/foods12040855

AMA Style

Li Z-T, Han S-X, Pu J-Y, Wang Y-Y, Jiang Y, Gao M-J, Zhan X-B, Xu S. In Vitro Digestion and Fecal Fermentation of Low-Gluten Rice and Its Effect on the Gut Microbiota. Foods. 2023; 12(4):855. https://doi.org/10.3390/foods12040855

Chicago/Turabian Style

Li, Zhi-Tao, Shuang-Xin Han, Jia-Yang Pu, Yu-Ying Wang, Yun Jiang, Min-Jie Gao, Xiao-Bei Zhan, and Song Xu. 2023. "In Vitro Digestion and Fecal Fermentation of Low-Gluten Rice and Its Effect on the Gut Microbiota" Foods 12, no. 4: 855. https://doi.org/10.3390/foods12040855

APA Style

Li, Z. -T., Han, S. -X., Pu, J. -Y., Wang, Y. -Y., Jiang, Y., Gao, M. -J., Zhan, X. -B., & Xu, S. (2023). In Vitro Digestion and Fecal Fermentation of Low-Gluten Rice and Its Effect on the Gut Microbiota. Foods, 12(4), 855. https://doi.org/10.3390/foods12040855

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop